newsfilter
← Latest News
GlobeNewswire·

Genocea Provides Fourth Quarter 2020 Corporate Update

GEN-011 and GEN-009 clinical trials continue to advance ATLASTM stimulatory antigen and inhibitory antigen (InhibigenTM) identification profiled in Cancer Discovery Announcing SARS-CoV-2 T cell...